Rare disease detection: new study measures porphyria prevalence in symptomatic patients

This completed study aimed to find out how many patients with a certain set of symptoms actually have acute hepatic porphyria (AHP), a rare metabolic disorder. Researchers enrolled 150 adults aged 18 to 60 who had severe abdominal pain along with neurological symptoms like limb weakness, anxiety, or rapid heartbeat. They used urine tests to measure specific substances (delta-aminolevulinic acid and porphobilinogen) to confirm or rule out AHP. The goal was to improve diagnosis in patients whose initial tests for other conditions came back negative.